Skip to main content
Birkhäuser

The Grand Challenge for the Future

Vaccines for Poverty-Related Diseases from Bench to Field

  • Book
  • © 2005

Overview

  • Discussion of issues critical for the introduction of new vaccines
  • Highlights potential benefits for public health
  • Vaccine-related economic aspects
  • New perspective of the design of vaccination strategies
  • Includes supplementary material: sn.pub/extras

Part of the book series: Birkhäuser Advances in Infectious Diseases (BAID)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (13 chapters)

  1. Background

  2. Private hand

  3. Bench

  4. Clinical trials

Keywords

About this book

The most urgently needed vaccines are those against poverty-related diseases such as tuberculosis, malaria and HIV. However, there is a considerable gap between the development of a vaccine and the implementation as a useful measure for disease control. Major obstacles need to be overcome even after successful completion of the preclinical stage.

This book provides an important link between vaccine development and application under the particular conditions in developing countries.
The editors, S.H.E. Kaufmann and P.H. Lambert – one from the field of basic research and the other an expert on the side of applied vaccinology – have gathered contributions from specialists of both fields in an attempt to create a source of information that has thus far not been available.

Reviews

"The book gives a useful insight into many aspects of practical vaccinology. The recent availability of new funding through the Gates Foundation, the Global Alliance for Vaccines and Immunization, and the Vaccine Fund will open new opportunities for vaccination programmes in countries of th edeveloping world."

(Microbiology Today) 

Editors and Affiliations

  • Max Planck Institute for Infection Biology, Berlin, Germany

    Stefan H.E. Kaufmann

  • CMU — Centre of Vaccinology, Geneva 4, Switzerland

    Paul-Henri Lambert

Bibliographic Information

Publish with us